This map shows the geographic impact of J Tošner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Tošner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Tošner more than expected).
This network shows the impact of papers produced by J Tošner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Tošner. The network helps show where J Tošner may publish in the future.
Co-authorship network of co-authors of J Tošner
This figure shows the co-authorship network connecting the top 25 collaborators of J Tošner.
A scholar is included among the top collaborators of J Tošner based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with J Tošner. J Tošner is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Sedláková, Iva, Ján Laco, J Tošner, & Jiří Špaček. (2015). [Prognostic significance of Pgp, MRP1, and MRP3 in ovarian cancer patients].. PubMed. 80(6). 405–13.5 indexed citations
Jílek, Petr, et al.. (2013). [Hypersensitivity reactions to carboplatin and paclitaxel - our five-years experiences].. PubMed. 78(6). 514–21.1 indexed citations
5.
Sedláková, Iva, Ján Laco, J Tošner, Jiří Špaček, & Eva Čermáková. (2013). [Drug resistance proteins LRP, Pgp, MRP1, MRP3 and MRP5 in ovarian cancer patients].. PubMed. 78(6). 545–53.5 indexed citations
6.
Sedláková, Iva, et al.. (2012). [Proteins of resistance and drug resistance in ovarian carcinoma patients].. PubMed. 25(6). 457–63.6 indexed citations
Andrýs, Ctirad, Marcela Drahošová, Helena Hornychová, et al.. (2010). Umbilical cord blood concentrations of IL-6, IL-8, and MMP-8 in pregnancy complicated by preterm premature rupture of the membranes and histological chorioamnionitis.. PubMed. 31(6). 857–63.22 indexed citations
Kacerovský, Marián, Marcela Drahošová, Helena Hornychová, et al.. (2009). Value of amniotic fluid interleukin-8 for the prediction of histological chorioamnionitis in preterm premature rupture of membranes.. PubMed. 30(6). 733–8.35 indexed citations
14.
Kacerovský, Marián, J Tošner, Ctirad Andrýs, et al.. (2009). [Amniotic fluid heat shock protein 70 concentration in preterm premature rupture of membranes].. PubMed. 74(2). 85–91.2 indexed citations
15.
Kacerovský, Marián, Marcela Drahošová, Helena Hornychová, et al.. (2009). [Amniotic fluid interleukin 6 levels in preterm premature rupture of membranes].. PubMed. 74(6). 403–10.3 indexed citations
Velemínský, Miloš, et al.. (2008). Relationship of amniotic-type placenta inflammation to pPROM, PROM and risk of early onset neonatal sepsis.. PubMed. 29(4). 447–50.5 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.